Teriparatide
Therapeutic Group
Drugs For Treatment Of Bone DiseasesIndication Dosage
Treatment Of Osteoporosis In Postmenopausal Women And In Men At Increased Risk Of Fractures, Treatment Of Corticosteroid-induced Osteoporosis:
By Sc Inj:
- Adult: 20 Micrograms Daily For Maximum Duration Of Treatment 24 Months (course Not To Be Repeated)
Content
- Inj: Per ml: Teriparatide 250 Mcg; 3 ml Pre-Filled Pen For 28 Doses.
Pregnancy
Contraindicated
Stability
- Recombinant Parathyroid Hormone and Analogue
Contra Indications
- Bone Metastases, Hyperparathyroidism Metabolic Bone Diseases, Paget's Disease, Pre-existing Hypercalcaemia, Previous Radiation, Therapy To The Skeleton, Skeletal Malignancies, Unexplained Raised Alkaline Phosphatase
Precautions
- Bone Metastases, Hyperparathyroidism Metabolic Bone Diseases, Paget's Disease, Pre-existing Hypercalcaemia, Previous Radiation, Therapy To The Skeleton, Skeletal Malignancies, Unexplained Raised Alkaline Phosphatase
Lactation
- Contraindicated
Side Effects
- Anaemia
- Arthralgia
- Asthenia
- Depression
- Dizziness
- Dyspnea
- Fatigue
- Gi Disorders
- Haemorrhoids
- Headache
- Increased Sweating
- Muscle Cramps
- Myalgia
- Nausea
- Palpitation
- Reflux
- Sciatica
- Vertigo
- Hypercalcaemia
- Injection-site Reactions
- Urinary Disorders.
- Rare: Hypersensitivity Reactions